The Dr. Brighten Show
The Dr. Brighten Show
Podcast Description
Dr. Jolene Brighten, a best-selling author, naturopathic endocrinologist, and women’s health expert, hosts The Dr. Brighten Show—a podcast dedicated to igniting transformative conversations in women’s health. Through candid interviews with leading experts, innovators, and thought-leaders, this show brings you groundbreaking research, personal stories, and practical tools to help you confidently navigate your body and hormones. It’s a fun, engaging, and insightful journey designed to empower you with tangible, science-backed insights—so you can live your best, most vibrant life.
Podcast Insights
Content Themes
The podcast focuses on women's health, hormonal balance, and chronic conditions, with episodes on diverse topics like pelvic pain management, metabolic health, and perimenopause, offering groundbreaking insights from leading experts like Dr. Ana Sierra and Dr. Elisa Song.
Dr. Jolene Brighten, a best-selling author, board certified naturopathic endocrinologist, and women’s health expert, hosts The Dr. Brighten Show—a podcast dedicated to igniting transformative conversations in women’s health. Through candid interviews with leading experts, innovators, and thought-leaders, this show brings you groundbreaking research, personal stories, and practical tools to help you confidently navigate your body and hormones. It’s a fun, engaging, and insightful journey designed to empower you with tangible, science-backed insights, so you can live your best, most vibrant life.
If you’ve been wondering whether Ozempic, semaglutide, tirzepatide, or other GLP-1 medications could help with endometriosis symptoms, chronic pelvic pain, adhesions, fatigue, or endo belly, you are not alone. More and more women with endometriosis are reporting that GLP-1 medications may be helping with symptoms that go far beyond weight loss, from lower inflammation and less pain to improved energy and better blood sugar stability.
But what does the science actually say?
In this episode of The Dr. Brighten Show, Dr. Jolene Brighten breaks down the emerging research and real-world clinical observations around GLP-1 receptor agonists and endometriosis, including what is currently known, what remains theoretical, and why this conversation may be one of the most important developments in women’s health right now.
You’ll learn how GLP-1 medications like Ozempic (semaglutide), Wegovy, Mounjaro (tirzepatide), liraglutide, and exenatide may influence inflammatory signaling, fibrosis, metabolic dysfunction, and long-term cardiovascular risk in women living with endometriosis.
This Episode Is Brought to You By
This episode is brought to you by The Endometriosis Reset, my step-by-step program designed to help women address the full-body drivers of endometriosis symptoms, including inflammation, blood sugar instability, endo belly, fatigue, scar tissue support, and nervous system dysregulation.
Inside the program, I walk you through clear protocols for nutrition, supplement timing and dosing, lifestyle support, and the conversations to have with your doctor so you can stop piecing together conflicting advice online.
Learn more at http://drbrighten.com/endocourse
EndoGlobal Group
At EndoGlobal Group, a network of world-class endometriosis specialists comes together to provide comprehensive, multidisciplinary care for patients with complex endometriosis—offering advanced diagnostic mapping, complete excision surgery, and holistic support.
Click here to learn more and schedule a free consultation https://drbrighten.com/endoglobal
👩🏻⚕️Follow Dr. Jolene Brighten:
💻 Website: https://www.drbrighten.com
📸 Instagram:https://www.instagram.com/drjolenebrighten
🎥 TikTok: https://www.tiktok.com/@drjolenebrighten
🧵Threads: https://www.threads.net/@drjolenebrighten
🌟 Grab my free hormone friendly recipes here! https://drbrighten.com/hormonekit/
🎧 Subscribe to the Podcast:
YouTube: https://www.youtube.com/@drjolenebrighten
👉 If you found this episode valuable, drop a comment below to tell us what you loved most, and share it with a friend! Let’s spread the knowledge. 💬
Learn more about your ad choices. Visit megaphone.fm/adchoices
Disclaimer
This podcast’s information is provided for general reference and was obtained from publicly accessible sources. The Podcast Collaborative neither produces nor verifies the content, accuracy, or suitability of this podcast. Views and opinions belong solely to the podcast creators and guests.
For a complete disclaimer, please see our Full Disclaimer on the archive page. The Podcast Collaborative bears no responsibility for the podcast’s themes, language, or overall content. Listener discretion is advised. Read our Terms of Use and Privacy Policy for more details.